Gilead Latin America & Caribbean Grants


View website Save this grant

Deadline: Rolling

Grant amount: Unspecified amount

Fields of work: Health Care Access & Delivery Health Disparities & Social Determinants of Health Medical Education & Professional Training HIV/AIDS Human & Social Services STEM Education Public / Community Art Greening & Beautification Diseases & Conditions Show all

Applicant type: Nonprofit

Funding uses: Project / Program, Education / Outreach

Location of project: Anguilla; Antigua and Barbuda; Argentina; Aruba; Bahamas Show all

Location of residency: Anguilla; Antigua and Barbuda; Argentina; Aruba; Bahamas Show all


NOTE: Grant applications are accepted throughout the year. Funding requests must be submitted a minimum of 8 weeks prior to the start of the activity. The typical grant review timeline can be up to 12 weeks.

What We Fund

Gilead welcomes funding requests for innovative, high impact projects that relate to at least one of our core therapeutic areas:

  • HIV
  • Liver disease
    • HCV
    • HBV
    • HDV
  • Oncology
    • Hematology
    • Solid tumors
  • Inflammatory and respiratory diseases

We consider a number of factors when reviewing grant requests, but it is most important for applications to demonstrate a strong commitment to — and capacity for — delivering the specific services your funded grant would support.

Types of Organizations We Support

Patient Community Support:

Lack of awareness is often a significant barrier to disease screening and treatment — especially among at-risk populations — leading to acute disparities in care. Gilead supports patients and their communities by funding a variety of awareness-raising projects.

Examples of Patient Community Support projects Gilead has funded include:

  • Events or resources to educate patients about prevention and care options, such as:
    • Presentations
    • Web-based resources
    • Printed materials
    • Testing and screening initiatives
  • The types of Patient Community Support organizations Gilead has funded include:
    • Patient advocacy and support groups
    • Hospitals and clinics
    • Nonprofit service organizations
    • Professional associations
    • Academic medical centers and universities

Medical & Scientific Support:

Ongoing education is essential to ensuring that healthcare professionals can continue to deliver the best possible care based on the latest advances in medicine. Gilead supports high-impact, continuing medical education programs that expand the knowledge and skills of healthcare professionals.

Gilead has funded a range of Medical and Scientific Support projects, including:

  • Continuing medical education (CME) accredited by ACCME or another relevant organization
  • Non-accredited CME in compliance with FDA guidelines
  • Scientific conferences
  • Lecture series or symposia

Please remember that attendance at Medical and Scientific Support events should be open to professionals in the community. The principal speaker may not be employed by, or the audience limited to, the funded organization.

The types of Medical and Scientific Support organizations Gilead has funded include:

  • Medical universities
  • Professional associations
  • Community health centers
  • Hospitals and academic medical centers

If you represent an accredited medical education program that involves for-profit medical education companies or that has a national or regional scope (e.g., satellite symposia at scientific conferences), Gilead offers a separate application and review process managed by the Gilead Independent Medical Education Department (IMED).

Giving in Latin America and the Caribbean

For many years, Gilead has worked with local partners to provide our medicines throughout Latin America and the Caribbean. Gilead therapies continue to address unmet medical needs in the region, bringing innovative and life-saving treatments to communities in Argentina, Belize, Brazil, Haiti, Jamaica and elsewhere. The efforts of our corporate contributions team build upon our overall mission, as we identify and support organizations that seek to:

  • Improve access to healthcare
  • Reduce disparities for disadvantaged groups
  • Advance education among patients and healthcare professionals
  • Support local communities

Focus Areas


Gilead places a strong emphasis on combating the HIV epidemic in Latin America and the Caribbean. Despite advancements in medicines and treatments, HIV’s devastating and inequitable impact remains, particularly among indigenous people living in remote regions of Peru as well as young people throughout Latin America. In the Caribbean, more than 230,000 people are living with the disease, making the region’s HIV prevalence the second highest of anywhere in the world.

In other populous areas, the social stigma of HIV-positive status leads many to decline treatment or travel great distances to be treated outside their community. Elsewhere, poor treatment options for incarcerated populations (a group that faces systemic barriers to receiving quality HIV care) leads to public health concerns as individuals complete their rehabilitation programs and re-enter society.

Gilead supports organizations working to help individuals learn their status and get the care they need. We also fund groups looking to meet the unique needs of the region, including:

  • Increasing awareness and understanding of HIV incidence and treatment methods
  • Facilitating medicine provision and local provider expertise
  • Supporting linkage to care programs
  • Identifying and fostering prevention programs for at-risk individuals; for example, via pre-exposure prophylaxis (PrEP)

Liver Disease:

Treating Hepatitis B (HBV), Hepatitis C (HCV) and other forms of liver disease can be a challenge in Latin America and the Caribbean for a variety of reasons. One critical difficulty centers on reaching at-risk groups with screening and diagnosis. The estimated percentage of undiagnosed individuals living with HCV in Latin America and the Caribbean has gone unchanged over the span of many years. Lack of disease awareness and diagnosis options have contributed to the persistence of this gap. Even in areas where intravenous drug use and other behaviors that can increase risk are better understood, many hospital procedures are not performed in sterile conditions, with individuals contracting viral hepatitis in the process.

Our grantee partners seek to increase awareness of risk factors and the educational tools available to patient communities throughout the region. Gilead also funds projects to improve diagnostics and build medical specialization in HBV and HCV.

Gilead is working to improve the overall continuum of care for liver diseases by funding organizations that:

  • Ensure providers have the training and expertise they need to deliver proper care
  • Improve infrastructure and screening ability of regions where care is dependent on viral load
  • Reduce undiagnosed totals
  • Increase awareness of risk factors


Though priority is given to projects related to HIV- and liver disease-related projects, Gilead will consider grant proposals outside of these therapeutic areas, provided they conform to our eligibility restrictions. These proposals may include (but are not limited to):

  • Access and education surrounding antifungal treatments
  • Social services (homeless shelters, food banks, etc.)
  • Community vibrancy projects (STEM education, arts support, community beautification, etc.)


There are no minimum or maximum request amounts. Applicants should request the level of funding that is required based on programmatic needs.

You can learn more about this opportunity by visiting the funder's website.


  • We work with patient advocates, nonprofits, and healthcare professionals across all our therapeutic areas of focus to improve care through partnerships and community engagement.
  • Grant funding is primarily awarded for direct programmatic support. 


  • In Latin America and the Caribbean, funding priority is given to projects within Gilead’s therapeutic areas of HIV and liver diseases.


  • Grants may not be provided:
    • To pay for patient care or treatment and/or prescriptions
    • To pay for general operating expenses or purchase of standard equipment or hardware
    • To support a healthcare practitioner’s expenses for attendance or travel to educational programs
    • To individual healthcare professionals or for-profit physician group practices
    • To pay honoraria of healthcare providers employed by or affiliated with the requesting organization
    • To support the costs of government lobbying activities 
    • To compensate individuals who provide services to Gilead, such as speaking or advising
    • To serve in lieu of a discount or price concession or as part of a contract negotiation
    • To support clinical studies
  • Gilead generally does not provide grant support for indirect costs of an organization or activity.


Your history with this funder
No saved opportunities from this funder yet
Save this opportunity to add notes...
Save this opportunity to add contacts...

This page was last reviewed November 27, 2023 and last updated November 27, 2023